Related Experiment Video
Updated: May 20, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
The viral RNA capping machinery as a target for antiviral drugs
François Ferron1, Etienne Decroly, Barbara Selisko
1Centre National de la Recherche Scientifique and Aix-Marseille Université, UMR 7257, Architecture et Fonction des Macromolécules Biologiques, 163 Avenue de Luminy, 13288 Marseille Cedex 09, France.
Abstract:
Most viruses modify their genomic and mRNA 5'-ends with the addition of an RNA cap, allowing efficient mRNA translation, limiting degradation by cellular 5'-3' exonucleases, and avoiding its recognition as foreign RNA by the host cell. Viral RNA caps can be synthesized or acquired through the use of a capping machinery which exhibits a significant diversity in organization, structure and mechanism relative to that of their cellular host. Therefore, viral RNA capping has emerged as an interesting field for antiviral drug design. Here, we review the different pathways and mechanisms used to produce viral mRNA 5'-caps, and present current structures, mechanisms, and inhibitors known to act on viral RNA capping.
Related Concept Videos
Viruses with RNA Genomes
Retrovirus Life Cycles
Viral Structure
Subviral Agents
Inhibitors of Viral Protein Synthesis
The Antiviral System of Bacteria and Archaea: CRISPR

